• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 - 2020年西澳大利亚州慢性肾脏病患病率

Prevalence of chronic kidney disease in Western Australia, 2010-2020.

作者信息

Mehta Kanika, Randall Sean, Lee Crystal Man Ying, Thomas Elizabeth, Chakera Aron, Chai Kevin, Estai Mohamed, Frith Madison, Hendrie Delia, Boyd James, Robinson Suzanne

机构信息

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.

Deakin Health Economics, Institute for Health Transformation, Deakin University, Melbourne, Victoria, Australia.

出版信息

BMJ Open. 2025 Jan 28;15(1):e092320. doi: 10.1136/bmjopen-2024-092320.

DOI:10.1136/bmjopen-2024-092320
PMID:39880441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11781091/
Abstract

OBJECTIVE

To assess the prevalence and trends of chronic kidney disease (CKD) in Western Australia (WA) from 2010 to 2020 using linked pathology data.

DESIGN

A retrospective observational cohort study using linked de-identified data from WA pathology providers, hospital morbidity records and mortality records.

SETTING

A Western Australian population-based study.

PARTICIPANTS

All individuals aged 18 years and older with at least one serum creatinine test.

PRIMARY OUTCOME MEASURE

CKD status as determined by estimated glomerular filtration rate and urine albumin-creatinine ratio.

RESULTS

Analysing data from 2 501 188 individuals, there was a significant increase in age-sex standardised CKD prevalence from 4.7% in 2010 to 6.0% in 2020, with annual average percentage change of 3.0% (95% CI: 2.3% to 3.7%). Prevalence of CKD stages 3 and above was 4.8% in 2020. Higher CKD prevalence was observed in regional and remote areas compared with major cities, and among individuals in the most socioeconomically disadvantaged quintiles. Sensitivity analysis indicated minor impacts from data exclusions and methodological choices.

CONCLUSIONS

CKD prevalence in WA has been steadily increasing, reflecting broader Australian trends. The study highlights significant disparities in CKD prevalence based on age, socioeconomic status and geographic remoteness.

摘要

目的

利用关联病理数据评估2010年至2020年西澳大利亚州(WA)慢性肾脏病(CKD)的患病率及趋势。

设计

一项回顾性观察队列研究,使用来自西澳大利亚州病理机构、医院发病率记录和死亡率记录的关联匿名数据。

背景

一项基于西澳大利亚州人群的研究。

参与者

所有年龄在18岁及以上且至少进行过一次血清肌酐检测的个体。

主要观察指标

根据估计肾小球滤过率和尿白蛋白肌酐比值确定的CKD状态。

结果

分析2501188名个体的数据,年龄性别标准化的CKD患病率从2010年的4.7%显著增加到2020年的6.0%,年平均变化百分比为3.0%(95%CI:2.3%至3.7%)。2020年3期及以上CKD的患病率为4.8%。与主要城市相比,在地区和偏远地区以及社会经济最弱势五分之一人群中观察到更高的CKD患病率。敏感性分析表明数据排除和方法选择的影响较小。

结论

西澳大利亚州CKD患病率一直在稳步上升,反映了澳大利亚更广泛的趋势。该研究突出了基于年龄、社会经济地位和地理偏远程度的CKD患病率的显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/b1403289233c/bmjopen-15-1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/a5c3db989010/bmjopen-15-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/80891909ea8c/bmjopen-15-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/a17d2a252280/bmjopen-15-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/e4efd9256061/bmjopen-15-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/b1403289233c/bmjopen-15-1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/a5c3db989010/bmjopen-15-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/80891909ea8c/bmjopen-15-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/a17d2a252280/bmjopen-15-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/e4efd9256061/bmjopen-15-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd40/11781091/b1403289233c/bmjopen-15-1-g005.jpg

相似文献

1
Prevalence of chronic kidney disease in Western Australia, 2010-2020.2010 - 2020年西澳大利亚州慢性肾脏病患病率
BMJ Open. 2025 Jan 28;15(1):e092320. doi: 10.1136/bmjopen-2024-092320.
2
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
3
Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation.使用PREVENT方程对美国慢性肾脏病患者群体进行心血管疾病风险评估。
Am J Kidney Dis. 2025 Mar 5. doi: 10.1053/j.ajkd.2025.01.012.
4
Antioxidants for chronic kidney disease.用于慢性肾病的抗氧化剂。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008176. doi: 10.1002/14651858.CD008176.pub2.
5
Disease Awareness in Patients With Type 2 Diabetes: Analysis of Baseline Data From the SMART-Finder Observational Study.2型糖尿病患者的疾病认知:来自SMART-Finder观察性研究的基线数据分析
JMIR Form Res. 2025 Feb 18;9:e60246. doi: 10.2196/60246.
6
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
7
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
9
Adoption of CKD-EPI (2021) for Glomerular Filtration Rate Estimation: Implications for UK Practice.采用CKD-EPI(2021)估算肾小球滤过率:对英国实践的影响。
Nephron. 2025;149(3):133-148. doi: 10.1159/000541689. Epub 2024 Sep 28.
10
High prevalence of unrecognized chronic kidney disease in the Lolland-Falster Health Study: a population-based study in a rural provincial area of Denmark.洛兰-法尔斯特健康研究中未被识别的慢性肾脏病的高患病率:丹麦一个农村省级地区的一项基于人群的研究。
Eur J Public Health. 2025 Jun 1;35(3):449-455. doi: 10.1093/eurpub/ckae208.

本文引用的文献

1
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset.澳大利亚初级医疗中慢性肾脏病的患病率:一项全国性全科医疗数据集分析
Kidney Int Rep. 2023 Nov 29;9(2):312-322. doi: 10.1016/j.ekir.2023.11.022. eCollection 2024 Feb.
2
Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance.中国慢性肾脏病患病率:来自第六次中国慢性病及其危险因素监测的结果。
JAMA Intern Med. 2023 Apr 1;183(4):298-310. doi: 10.1001/jamainternmed.2022.6817.
3
Unlocking Potential within Health Systems Using Privacy-Preserving Record Linkage: Exploring Chronic Kidney Disease Outcomes through Linked Data Modelling.
利用隐私保护记录链接在卫生系统中挖掘潜力:通过关联数据建模探索慢性肾脏病结局。
Appl Clin Inform. 2022 Aug;13(4):901-909. doi: 10.1055/s-0042-1757174. Epub 2022 Sep 28.
4
Island medicine: using data linkage to establish the kidney health of the population of Tasmania, Australia.岛医:利用数据链接来评估澳大利亚塔斯马尼亚岛人群的肾脏健康状况。
Int J Popul Data Sci. 2021 Aug 3;6(1):1665. doi: 10.23889/ijpds.v6i1.1665. eCollection 2021.
5
Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: A systematic review and meta-analysis.慢性肾脏病患者焦虑症状和焦虑障碍的患病率及危险因素:系统评价和荟萃分析。
Gen Hosp Psychiatry. 2021 Mar-Apr;69:27-40. doi: 10.1016/j.genhosppsych.2020.12.003. Epub 2020 Dec 15.
6
Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016.英格兰成年人慢性肾脏病患病率:2003年至2016年全国代表性横断面调查比较
BMJ Open. 2020 Aug 13;10(8):e038423. doi: 10.1136/bmjopen-2020-038423.
7
Epidemiology of chronic kidney disease in Australian general practice: National Prescribing Service MedicineWise MedicineInsight dataset.澳大利亚普通实践中慢性肾病的流行病学:国家处方服务 MedicineWise MedicineInsight 数据集。
Nephrology (Carlton). 2019 Oct;24(10):1017-1025. doi: 10.1111/nep.13537. Epub 2018 Dec 13.
8
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率:2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
9
How common is multiple general practice attendance in Australia?在澳大利亚,有多少人同时在多个全科医生诊所就诊?
Aust J Gen Pract. 2018 May;47(5):289-296. doi: 10.31128/AJGP-11-17-4413.
10
Associations between socioeconomic status and chronic kidney disease: a meta-analysis.社会经济地位与慢性肾脏病的关系:一项荟萃分析。
J Epidemiol Community Health. 2018 Apr;72(4):270-279. doi: 10.1136/jech-2017-209815. Epub 2018 Feb 2.